HANOI -- A Vietnamese pharmaceutical company has begun second phase trials on a coronavirus vaccine, an important step toward Hanoi's goal of vaccine independence from China amid rising territorial tensions between the countries.
If the trials are successful, Nanogen Pharmaceutical Biotechnology's Nano Covax vaccine is expected to be approved for emergency use as early as May. A quick rollout is crucial for Vietnam, which seeks to keep Beijing from exerting influence through its so-called vaccine diplomacy in Southeast Asia.
